Hand-Foot Syndrome (Palmar-Plantar Erythrodysesthesia) Support Protocol

Oncology/Side Effect ManagementLimited Evidence

supplements

Primary

Supporting

Grade A

Studies

Primary Stack

Core supplements with strongest evidence

Vitamin B6 (Pyridoxine)B

50-200mg daily (discuss with oncologist)

May help prevent or reduce HFS with certain chemotherapy drugs

↓Hand-Foot Syndrome Symptoms

8 studies500 participants

Supporting Studies (1)

PMID: 27450775 - Pyridoxine for hand-foot syndrome: meta-analysis (2016)

Supporting Stack

Additional supplements for enhanced results

Vitamin E (Topical)C

Apply topical vitamin E oil to hands/feet twice daily

Moisturizing and antioxidant; may soothe affected skin

↓Hand-Foot Syndrome Symptoms

4 studies150 participants

Supporting Studies (1)

PMID: 23075608 - Topical vitamin E for HFS: clinical observations (2012)

Urea Cream (10-40%)B

Apply to affected areas twice daily

Keratolytic and moisturizing; reduces hyperkeratosis

6 studies300 participants

Supporting Studies (1)

PMID: 25850163 - Topical treatments for HFS: review (2015)

Omega-3 Fatty AcidsC

2-3g EPA+DHA daily

Anti-inflammatory; may support skin health

3 studies100 participants

Supporting Studies (1)

PMID: 27840029 - Omega-3 for skin inflammation: review (2017)

How This Protocol Works

Simple Explanation

Hand-foot syndrome (HFS), also called palmar-plantar erythrodysesthesia (PPE), is a side effect of certain chemotherapy drugs that causes redness, swelling, and pain on the palms of hands and soles of feet.

SYMPTOMS:

•Redness (like sunburn)

•Swelling

•Tingling or burning sensation

•Tenderness

•Blisters or peeling skin

•Pain affecting daily activities

COMMON CAUSES:

•Capecitabine (Xeloda)

•5-Fluorouracil (5-FU)

•Doxorubicin (liposomal)

•Sorafenib, sunitinib (targeted therapies)

•Cytarabine

GRADES:

•Grade 1: Redness, minimal discomfort

•Grade 2: Painful redness, swelling, affects function

•Grade 3: Severe; blistering, ulceration, can't use hands/feet

PREVENTION & MANAGEMENT:

•Avoid friction, heat, pressure on hands/feet

•Wear soft cotton gloves and socks

•Avoid hot water

•Use emollient creams frequently

•Avoid tight shoes

•May need dose reduction

* Vitamin B6 may help prevent HFS with some drugs.

* Urea creams help with dryness and peeling.

* Topical vitamin E may soothe skin.

Expected timeline: HFS typically appears 2-12 weeks after starting chemotherapy. Symptoms usually improve with dose modification and supportive care.

Clinical Perspective

Hand-Foot Syndrome: Cutaneous toxicity from chemotherapy, especially capecitabine, 5-FU, liposomal doxorubicin, TKIs. Incidence varies by drug (30-70% with capecitabine). Grading: mild (1) to severe (3). May require dose reduction or interruption.

Management: Prevention - emollients, avoid friction/heat. Treatment: topical urea creams, emollients, pyridoxine (mixed evidence), dose modification. Pyridoxine 50-200mg studied with variable results. Urea-based creams for hyperkeratosis. Severe cases need dose reduction/interruption. COX-2 inhibitors being studied. Always discuss with oncologist.

* Vitamin B6 (B-grade): Prevention/treatment. Meta-analysis: (PMID: 27450775). 50-200mg daily.

* Vitamin E Topical (C-grade): Moisturizing. Clinical observations: (PMID: 23075608). Apply BID.

* Urea Cream (B-grade): Keratolytic. Review: (PMID: 25850163). 10-40% BID.

* Omega-3 (C-grade): Anti-inflammatory. Review: (PMID: 27840029). 2-3g EPA+DHA daily.

Protocol notes: Prevention: start moisturizers before chemotherapy starts. Pyridoxine: evidence mixed; more positive with capecitabine. Cooling: ice during infusion may help (doxorubicin). Urea: 10% for mild; 40% for hyperkeratotic. Emollients: lanolin-based; apply frequently. Footwear: well-fitting, soft soles. Gloves: soft cotton; avoid friction. Hot water: avoid; use lukewarm. Dose modification: often necessary for grade 2+; discuss with oncologist. TKI-related: can have different pattern; targeted therapy-specific.

View All Protocols